Vikram Sinai Talaulikar @vikramsinait.bsky.social · 8hThe guidelines provide useful summary of current treatments as we know ‘one size does not fit all’. The one point that needs highlighting is that initiation and duration of treatment with HRT as well as type of hormones used should be individualised and not be based on arbitrary age/time limits. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 8h* Neurokinin receptor antagonists (NKRAs): elinzanetant and fezolinetant * Progestogen monotherapy * Selective serotonin reuptake inhibitors (SSRIs): citalopram, escitalopram, and paroxetine * Serotonin-norepinephrine reuptake inhibitors (SNRIs): desvenlafaxine and venlafaxine 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 8hThe guidelines provide recommendations and evidence base for following treatments * Alpha agonist: clonidine * Anticholinergic: oxybutynin * Estrogen monotherapy * Estrogen in combination with bazedoxifene * Estrogen in combination with progestogen * Gabapentinoid: gabapentin 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 8hHere are the latest Clinical Guidelines from the American College of Physicians for Pharmacologic Treatments for Females With Menopausal Vasomotor Symptoms. www.acpjournals.org/doi/10.7326/... 300
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 05/10/2026Please join us on the day by clicking the link or search menopause events on the RCGP website to register - engage.rcgp.org.uk/event/a2kWS0... Healthcare professionals can join even if you are not a RCGP member. Thank you Prof Aimee Spector & Dr Alba Soares Pereira for putting this together 🙏🏻.engage.rcgp.org.ukWelcome to LWC Communities! 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 05/10/2026There is so much new research being published about menopause, hormone changes, lifestyle, HRT, cognitive health & risk of dementia. What is certain at present and what is uncertain? We will try to address there topics in our upcoming RCGP event on 14th October. engage.rcgp.org.uk/event/a2kWS0... 100
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 05/10/2026From 5–9 October, organisations across the country will be celebrating/championing the work of specialist, associate specialist & specialty doctors and standing up for SAS doctors' rights in the workplace. A big thank you to British Medical Association for being a voice for the SAS professionals. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 05/10/2026It is the SAS Week 2026 The week to celebrate and support the invaluable SAS workforce by sharing success stories and values as per the SAS charter. www.nhsemployers.org/sasweek26 questionnaires.bma.org.uk/news/whoares... 121
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 04/10/2026Congratulations 🎉 Varda on your CREST Discovery Award for the project on “European Biodiversity Field Guide.” Thank you for all your hard work and dedication. A proud moment for us indeed! 🌿🔬🏆 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 02/10/2026Looking forward to the next year’s event. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 02/10/2026It is often the small changes at the local level that have the biggest impact on patient experiences rather than complex policies or documents. We will continue working hard at the ground level to keep making changes and improving the services. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 02/10/2026A big thank you to everyone who supported us along the way 🙏🏻. And apologies, I was breathless for my presentation - I had to run from St Pancras station to the RCGP due to delays on Victoria line and ended up getting to the presentation room 2 min before my start time 😅. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 02/10/2026And Gabriella Yongue presented the findings from our monthly multidisciplinary ‘menopause and cancer’ MDT which has improved access times to specialist clinical decision making for so many patients with complex clinical scenarios. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 02/10/2026This gave us vital insights into the gaps existing in current care models. Kawsar Al Dahaby presented the menopause information leaflet she designed for our department. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 02/10/2026It was wonderful to show case our team’s small efforts to collect feedback and improve menopause care experiences for our patients. I had the opportunity to present the findings from our large data set of over 1300 patients who responded to the Menopause and Cancer survey. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 02/10/2026Supported by UCLH Charity, the festival serves as a dedicated platform for hospital staff, medical professionals, and researchers to come together to collaborate, innovate, and share best practices across the Trust. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 02/10/2026It was wonderful to participate in the UCLH Festival of Excellence on Wednesday. This is an annual collaborative event hosted by University College London Hospitals NHS Foundation Trust. 700
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 01/10/2026The exhibition held in collaboration with ‘Menopause Support’ founded by Diane Danzebrink coincides with menopause awareness month and runs throughout October at Brunswick Square Gardens in London. Do visit if you can. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 01/10/2026As part of the Bloomsbury Festival, here is ‘Picturing our Menopause’ a unique exhibition from Elizabeth Dalziel which brings to life varied personal stories, portraits and perspectives on menopause. Thank you Elizabeth and Diane for the opportunity to be a small part of this story! 100
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 01/10/2026We will also discuss about how do we balance oestrogen and progestogen doses in HRT. Everyone and all questions welcome! Thank you Roger Prentis and Katie Day at Midlife Matters for this opportunity as always. 001
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 01/10/2026It’s time for yet another webinar! Join us in the evening today at 6:30 pm for a free webinar on - ‘Hormone Replacement Therapy - what are the different options and what do the current guidelines recommend?’. To join us - click www.tickettailor.com/events/rdpi/... 100
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 28/09/2026Thank you 🙏🏻 Ruth Wood and team. Just visit the website at UCL brain 🧠 sciences or click - www.ucl.ac.uk/brain-scienc...ucl.ac.ukTake PartThank you for considering taking part. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 28/09/2026Do take part in or share this research 🙏🏻 from My Menopause Brain (UCL). Every experience of menopause is unique and each bit of research adds valuable data to advance our understanding of the transition! Just visit the website at UCL brain 🧠 sciences or click - www.ucl.ac.uk/brain-scienc... 111
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 28/09/2026The course will cover - * Female reproductive physiology and pathophysiology * Diagnosis and management of menstrual, ovulatory and endocrine disorders * The safe use of contraceptive and hormone replacement therapies Do join us on coming Friday 2nd October. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 28/09/2026This Royal College of Obstetricians and Gynaecologists (RCOG) online event focuses on crucial topics in female reproductive endocrinology across the life course. rcog.eventsair.com/female-repro... 100
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026As a clinician, this paper has been a whole new learning for me and has introduced me to the world of menopause and 💵 economics. The next step will be to build up on the work of these amazing researchers from across the world 🌍 from Asia and Africa to Europe and the Americas. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026While the model identifies plausible mechanisms, its pathways remain theoretical and require validation with longitudinal financial data. 010
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026The model reframes midlife women’s financial behaviour as a dynamic biopsychosocial process highlighting adaptive responses to fluctuating cognitive and emotional resources and provides a conceptual framework to understand how menopausal cognitive changes may shape financial decision-making. 010
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026Menopausal symptom domains interact with sociocultural factors, such as employment conditions, caregiving responsibilities, and financial system design, to influence decision-making pathways. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026The BF-MC Model identifies four interrelated domains: (1) neurocognitive regulation, (2) affective-behavioral regulation, (3) sociostructural mediation, and (4) economic adaptation and resilience. 010
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026This study proposes a new conceptual framework - the Behavioral Finance-Menopausal Cognition (BF-MC) Model - a first of its kind, that integrates menopause-related cognitive, psychological, and sociostructural dynamics with behavioural finance theory. 010
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026These influences remain under-theorised within current behavioural economics models. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026Emerging evidence from the Menopause and Ageing Research in International Environments (MARIE) WP2a program suggests that the menopause transition brings about significant neurocognitive, emotional, and sociostructural changes that may influence financial decision-making processes. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026Traditional behavioural finance (which examines how cognitive biases, emotions, and context shape economic decision-making) often assumes cognitive stability, rationality, and consistent risk evaluation, based largely on male-dominated samples. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 27/09/2026Here is a paper on a unique menopause economics 💰 model developed by Dr Gayathri Delanerolle and colleagues. journals.lww.com/menopausejou... 910
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 26/09/2026* Better access to therapies and specialist care. Everyone living with and beyond cancer should have access to safe, effective menopause support, treatments and specialist services when they need them. menopauseandcancer.org/events/ #WorldMenopauseandCancerAwarenessDaymenopauseandcancer.orgEvents - Menopause and CancerYou can join our services, workshops, programs and events at any time during and after your active cancer treatment. We welcome people affected by all types of cancers. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 26/09/2026* Improved training for healthcare professionals. Healthcare teams need the knowledge, confidence and resources to recognise, discuss and manage treatment-induced menopause effectively. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 26/09/2026What needs to happen? * Menopause support must be embedded into pre-cancer treatment discussions & long-term cancer care planning. Everyone deserves to understand the potential impact of treatment on their hormonal health & quality of life before treatment begins, and to receive ongoing support. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 26/09/2026The review emphasises comprehensive menopause care for cancer survivors. It echos themes on 18th September this year (World Menopause and Cancer Awareness Day) when Menopause & Cancer CIC organised the first global menopause & cancer conference for health professionals & are calling for change. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 26/09/2026With immune checkpoint inhibitors, the principal challenge is distinguishing menopausal symptoms from immune-related endocrinopathies rather than avoiding hormone replacement therapy. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 26/09/2026Individualisation of treatment according to symptom burden using validated assessment tools and various systemic formulations of HRT are discussed. Potential interactions with contemporary anti-cancer therapies, thrombotic risks of medications and relevant pharmacokinetic interactions are discussed. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 26/09/2026It details when and how long hormone replacement therapy should be initiated/continued after induced menopause and how ovarian recovery should be assessed following chemotherapy before confirming permanent ovarian insufficiency. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 26/09/2026It includes treatment eligibility, hormone replacement therapy initiation, regimen selection, duration of therapy, drug-drug interactions, and long-term follow-up. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 26/09/2026This is a very useful review from Blanca Gil-Ibáñez et al. which summarises current evidence and international guideline recommendations to provide a practical framework for menopause management in gynaecological cancer survivors, pubmed.ncbi.nlm.nih.gov/42660774/ 800
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 25/09/2026While many scientific frameworks rely strictly on menstrual cycle irregularity, others do not as these can cause gaps in clinical care. We will try and make sense of the current understanding of perimenopause and how best we can support patients in our clinics. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 25/09/2026Add in the mix of overlapping symptoms with chronic conditions & lack of regular menstruation caused by hormonal contraception or conditions like PMOS/hypothalamic suppression - medical frameworks, laboratory tests and public awareness struggle to keep up with the erratic nature of this transition. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 25/09/2026The confusion surrounding perimenopause stems from a fundamental medical reality: it is a state of hormonal fluctuations rather than a linear decline. Unlike menopause (a definitive end point) perimenopause is a highly unpredictable transition that disrupts definition, diagnosis, management. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 25/09/2026We will explore the current concepts and controversies about ‘perimenopause’. Perimenopause management divides opinions. There is lack of consensus on definition, diagnosis and management strategies. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 25/09/2026Gut health and the microbiome Management of perimenopause Decision-support tools in menopause care Interactive cases, quiz and Q&A Join us on 📅 27th November 2026 at📍 Bourne Hall, Ewell. 000
Vikram Sinai Talaulikar @vikramsinait.bsky.social · 25/09/2026Lots of practical talks and case discussions besides opportunity to network. We will cover - HRT and cancer risk Post-menopausal bleeding and novel diagnostics Pelvic health and physiotherapy in menopause 000